Testing the Safety of Bezlotoxumab to Treat C difficile in Children
Recently published data of bezlotoxumab dosing and safety in children with C diff was basis for expanding approval from just adults to as young as 1 years old.
Manipulation of the intestinal microbiome-a slow journey to primetime - PubMed
The gut microbiota has important functions in the regulation of normal body functions. Alterations of the microbiota are being increasingly linked to various disease states. The microbiome has been manipulated via the administration of stool from animals or humans, for more than 1000 years. C …
Current Therapeutics in Primary Sclerosing Cholangitis - PubMed
Primary sclerosing cholangitis (PSC) is an orphan, cholestatic liver disease that is characterized by inflammatory biliary strictures with variable progression to end-stage liver disease. Its pathophysiology is poorly understood. Chronic biliary inflammation is likely driven by immune dysregulation, …
Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans - PubMed
Off-the-shelf FMT requires recipient-independent optimized FMT selection. Such a transplant can be from an optimal donor or from a cultured set of microbes. We have here shown the feasibility of both types of manipulations in mouse and human recipients. Video Abstract.
Antibiotic Stewardship in Urologic Infections - George Koch
In this conversation, host Ruchika Talwar is joined by George Koch to discuss the importance of antibiotic stewardship in urology, exploring the reduction of unnecessary antibiotic loads in treating infections like Fournier's gangrene and recurrent UTIs. Dr. Koch emphasizes the careful selection and timing of antibiotics in perioperative prophylaxis and other conditions. Dr. Talwar points out...
Live Biotherapeutic Product (LBP) Market is Riding the Wave of Growth and Expected to Grow at a CAGR of 21.2 % to 2031 | Reveals Latest InsightAce Study
Companies covered in this report are Seres Therapeutics, Inc., Microbiotica, Enterome, Destiny Pharma plc, Taisho Pharmaceutical Holdings, AOBiome...
Antibiotics Can Mess With Your Gut. Here’s How Probiotics Can Help. - WTOP News
Your gut is a lively place. Bacteria of all kinds live in your intestines and, for the most part, help you to thrive. "The gut microbiome is a very complex ecosystem," says Dr. Geoffrey Preidis…
No Association Found Between COVID-19 Pandemic and Incidence of Health Care-Associated C. Difficile Infections
Prior studies had produced conflicting results on whether the pandemic positively or negatively impacted health care-associated C. difficile infections, yet the results of this current study indicate the pandemic played a limited role.
Microbiome and microbial therapy advances: takeaways from the Digestive Disease Week 2023
The Digestive Disease Week meeting 2023 covered a considerable variety of basic, translational, and clinical aspects of research in gastrointestinal and extraintestinal human health and disease. This post highlights the major takeaways from the Microbiome & Microbial Therapy sessions and unravels how they might impact daily basic research and clinical practice (part 2).
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection - PubMed
Our data indicate that different external and internal factors drive comparable profiles of low diversity dysbiosis. While diarrheal-related low diversity dysbiosis may be a consequence of systemic cancer therapy, a similar phenotype is observed in cases of moderate to severe IBD, and in both cases, …
Uncommon Presentation of Clostridioides difficile in the Small Bowel: A Case Report and Review of Literature
Clostridioides difficile infection (CDI) is a prevalent source of hospital-acquired diarrhea. The most common presentation of CDI is colitis. In cases of fulminant colitis/toxic megacolon, a col...
Acurx Pharma's Phase 2b Study Of Ibezapolstat In C. Difficile Infection On Track
(RTTNews) - Acurx Pharmaceuticals, Inc. (ACXP), while reporting financial results for the second quarter, on Monday, provided an update on its pipeline progress.
Clostridium Diagnostics Market Poised to Achieve US$7.8 Billion by 2032 with a Striking 12.2% CAGR
The global Clostridium Diagnostics Market is anticipated to grow at a 12.2% CAGR from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market saw a 13.6% CAGR between 2015 and 2021. The market is expanding as a result of increased awareness-raising activities for clostridium-related ill...
Healthcare-Associated Clostridioides difficile Infection: Learning the Perspectives of Healthcare Workers to Build Successful Strategies - PubMed
Our findings emphasize the importance of including frontline healthcare personnel in infection prevention decision-making processes and the strategies presented here can be applied to mitigating infections in different healthcare settings.
Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections - PubMed
In response to national guidelines, we implemented a two-step testing algorithm for Clostridioides difficile in an effort to improve diagnostic accuracy. Following implementation, we analyzed treatment frequency between discordant and concordant patients. We found that the majority of discordant cas …
Age-dependent modulation of gut microbiome in response to tumor immunomodulation - PubMed
In-situ vaccination (ISV) utilizing nanoparticles (NPs) and therapeutic devices like focused ultrasound (FUS) can trigger immune-mediated killing of both treated and untreated cancer cells. However, the impact of confounding factors such as aging and gut microbiota composition on therapeutic outcome …
Aged gut microbiota contribute to different changes in antioxidant defense in the heart and liver after transfer to germ-free mice - PubMed
Age-associated impairment in antioxidant defense is an important cause of oxidative stress, and elderly individuals are usually associated with gut microbiota (GM) changes. Studies have suggested a potential relationship between the GM and changes in antioxidant defense in aging animals. Direct evid …
A Comparison of Methods of Gut Microbiota Transplantation for Preclinical Studies - PubMed
The experimental details reported in preclinical fecal microbiota transplantation (FMT) protocols are highly inconsistent, variable, and/or incomplete. We therefore evaluated FMT from a human donor to antibiotic-induced microbial-depleted mice by exploring the effects of six techniques based on anti …
The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation - PubMed
(1) Background: Fecal microbiota transplantation (FMT) is an effective treatment for ulcerative colitis (UC). Metabolomic techniques would assist physicians in clinical decision-making. (2) Methods: Patients with active UC undergoing FMT were enrolled in the study and monitored for 3 months. We expl …
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review - PubMed
Neurogenic hypertension, a complex and multifactorial cardiovascular disorder, is known to be influenced by various genetic, environmental, and lifestyle factors. In recent years, there has been growing interest in the role of the gut microbiome in hypertension pathogenesis. The bidirectional commun …
The role of microbiome-based therapeutics for antimicrobial-resistant organism colonization - PubMed
The gut is host to a diverse array of microbiota that constitute a complex ecological system crucial to human physiology. Disruptors to the normal host microbiota, such as antimicrobials, can cause a loss of species diversity in the gut, reducing its ability to resist colonization by invading pathog …
Case report of SARS-CoV-2 with secondary Clostridioides difficile infection - PubMed
There has been an overuse of antibiotics in most patients suffering from COVID-19 which predisposes patients to hospital acquired C. difficile Infection (CDI). Also, COVID infection of the gastrointestinal tract also predisposes the patient to CDI. We here present a fatal case of SARS-CoV-2 coinfect …
Clostridioides difficile and Enterococci's Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review - PubMed
Clostridioides difficile and Enterococcus spp. are two common bacterial pathogens populating the human microbiota. We possess scant data on how Clostridioides difficile interacts with Enterococcus spp. in the gut microbiota in subjects colonized with Clostridioides dif …
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial - PubMed
FDA-approved microbiome therapy reduces recurrent CDI, regardless of risk factors
An FDA-approved oral fecal microbiota therapeutic reduces the risk for recurrent Clostridioides difficile infection in high-risk patients compared with placebo, regardless of demographics or baseline risk factors, researchers reported.